Symbol="CERS"
AssetType="Common Stock"
Name="Cerus Corporation"
Description="Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California."
CIK="1020214"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="537142000"
EBITDA="-38429000"
PERatio="None"
PEGRatio="0"
BookValue="0.281"
DividendPerShare="0"
DividendYield="0"
EPS="-0.26"
RevenuePerShareTTM="0.86"
ProfitMargin="-0.332"
OperatingMarginTTM="-0.268"
ReturnOnAssetsTTM="-0.124"
ReturnOnEquityTTM="-0.796"
RevenueTTM="153432000"
GrossProfitTTM="87094000"
DilutedEPSTTM="-0.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.052"
AnalystTargetPrice="7.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.742"
PriceToBookRatio="9.56"
EVToRevenue="4.324"
EVToEBITDA="-23.21"
Beta="1.027"
num_52WeekHigh="5.85"
num_52WeekLow="1.76"
num_50DayMovingAverage="2.479"
num_200DayMovingAverage="2.985"
SharesOutstanding="180552000"
DividendDate="None"
ExDividendDate="None"
symbol="CERS"
open="2.73"
high="2.85"
low="2.40"
price="2.44"
volume="2823967.00"
latest_trading_day="2023-08-03"
previous_close="2.98"
change="-0.54"
change_percent="-17.9832%"
aroon_positive_momentum_days="13"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="13"
Volume_recent_avg="1319916"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.34"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="13"
Aroon_momentum_negative="87"
image_negative_thumbnail_id_1="1120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_negative_thumbnail_id_2="174"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0002.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
